drugset / Trial / NCT03244280

A Study of the Systemic Absorption of MOB015B

NCT03244280

Phase 1 Completed 20 enrolled Moberg Pharma AB
NaSingle-groupOpen-labelOther

Summary

A Study of the Systemic Absorption of Once Daily MOB015B when Applied for 28 Days in Subjects with Moderate to Severe Onychomycosis of the Toenails.

Timeline

Start
2017-12-16
Primary completion
2018-04-23
Completion
2018-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Terbinafine Small molecule 10 % Topical

Indications